These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 11923115)
1. Cytokines as a link between innate and adaptive antitumor immunity. Belardelli F; Ferrantini M Trends Immunol; 2002 Apr; 23(4):201-8. PubMed ID: 11923115 [TBL] [Abstract][Full Text] [Related]
2. Dendritic cells and cytokines in immune rejection of cancer. Ferrantini M; Capone I; Belardelli F Cytokine Growth Factor Rev; 2008 Feb; 19(1):93-107. PubMed ID: 18054517 [TBL] [Abstract][Full Text] [Related]
8. Cytokines as critical co-stimulatory molecules in modulating the immune response of natural killer cells. Young HA; Ortaldo J Cell Res; 2006 Jan; 16(1):20-4. PubMed ID: 16467872 [TBL] [Abstract][Full Text] [Related]
9. Type I interferons as regulators of the differentiation/activation of human dendritic cells: methods for the evaluation of IFN-induced effects. Santini SM; Lapenta C; Belardelli F Methods Mol Med; 2005; 116():167-81. PubMed ID: 16000861 [TBL] [Abstract][Full Text] [Related]
10. Noncytolytic control of viral infections by the innate and adaptive immune response. Guidotti LG; Chisari FV Annu Rev Immunol; 2001; 19():65-91. PubMed ID: 11244031 [TBL] [Abstract][Full Text] [Related]
11. IFN-alpha in the generation of dendritic cells for cancer immunotherapy. Santini SM; Lapenta C; Santodonato L; D'Agostino G; Belardelli F; Ferrantini M Handb Exp Pharmacol; 2009; (188):295-317. PubMed ID: 19031032 [TBL] [Abstract][Full Text] [Related]
12. Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. Santini SM; Lapenta C; Logozzi M; Parlato S; Spada M; Di Pucchio T; Belardelli F J Exp Med; 2000 May; 191(10):1777-88. PubMed ID: 10811870 [TBL] [Abstract][Full Text] [Related]
13. Dendritic cells: translating innate to adaptive immunity. Steinman RM; Hemmi H Curr Top Microbiol Immunol; 2006; 311():17-58. PubMed ID: 17048704 [TBL] [Abstract][Full Text] [Related]
14. Gene therapy: development of immunostimulatory treatments for cancer. Gilligan MG; Knox PG; Searle PF Biotechnol Genet Eng Rev; 2000; 17():497-529. PubMed ID: 11255679 [No Abstract] [Full Text] [Related]
15. Modulation of antitumor immune responses by hematopoietic cytokines. Waller EK; Ernstoff MS Cancer; 2003 Apr; 97(7):1797-809. PubMed ID: 12655538 [TBL] [Abstract][Full Text] [Related]
16. Dendritic cell regulation of immune responses: a new role for interleukin 2 at the intersection of innate and adaptive immunity. Granucci F; Zanoni I; Feau S; Ricciardi-Castagnoli P EMBO J; 2003 Jun; 22(11):2546-51. PubMed ID: 12773371 [TBL] [Abstract][Full Text] [Related]
17. Mechanisms and implications of age-associated impaired innate interferon secretion by dendritic cells: a mini-review. Agrawal A Gerontology; 2013; 59(5):421-6. PubMed ID: 23615484 [TBL] [Abstract][Full Text] [Related]
18. Cytokines in the generation and maturation of dendritic cells: recent advances. Zou GM; Tam YK Eur Cytokine Netw; 2002; 13(2):186-99. PubMed ID: 12101074 [TBL] [Abstract][Full Text] [Related]
19. The impact of eicosanoids on the crosstalk between innate and adaptive immunity: the key roles of dendritic cells. Harizi H; Gualde N Tissue Antigens; 2005 Jun; 65(6):507-14. PubMed ID: 15896197 [TBL] [Abstract][Full Text] [Related]
20. Cellular therapies supplement: the role of granulocyte macrophage colony-stimulating factor and dendritic cells in regulatory T-cell homeostasis and expansion. Zou T; Satake A; Ojha P; Kambayashi T Transfusion; 2011 Nov; 51 Suppl 4(0 4):160S-168S. PubMed ID: 22074627 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]